Barrett's Esophagus with Esophageal Adenocarcinoma, T1b Submucosal Invasion, and High-Risk Tumor Histology
This protocol covers a specific high-risk presentation: esophageal adenocarcinoma arising in Barrett's esophagus with invasion into the submucosa (T1b stage) and high-risk histological features — a scenario that carries a substantially elevated risk of lymph node involvement and calls for a defined management pathway.
The patient has T1b esophageal adenocarcinoma (submucosal invasion) with high-risk tumor histology. Critically, the low-risk features are absent: there is no superficial sm1 invasion, no confirmed negative deep margin, no well-to-moderate differentiation, and lymphovascular invasion is not excluded. Esophagectomy has traditionally been recommended in this population given the high risk of lymph node metastases; candidacy for surgical resection is therefore a key consideration.
For patients in this high-risk category who are not suitable surgical candidates, an adjuvant approach — to be discussed and decided at a multidisciplinary conference — may be considered. The full protocol, including the complete treatment pathway, is available via the link below.
References
Esophagectomy has traditionally been recommended in patients with EAC with submucosal invasion (T1b EAC) given the high risk of lymph node metastases.
Patients with high-risk histology are best treated with esophagectomy, unless the patient is a poor surgical candidate, for whom discussion at a multidisciplinary conference may be appropriate to consider alternative options such as adjuvant chemoradiation.